Please select the option that best describes you:
Topics:
Cardiology • Interventional Cardiology
Do you avoid high-potency P2Y12 inhibitors in favor of clopidogrel in patients with atrial fibrillation on a DOAC who undergo PCI?
Answer from: at Community Practice
Not in all cases, favor high potency P2Y12 in high-risk coronary/complex anatomy, clopidogrel in high-risk bleeding patients.
Sign In or Register to read more